Edesa Biotech Inc (EDSA)

$4.46 0.15 (3.38%)

11:25 EDT EDSA Stock Quote Delayed 30 Minutes

EDSA Stock Earnings: Edesa Biotech Beats EPS for Q4 2023

By InvestorPlace Earnings Dec 18, 2023

EDSA stock results show that Edesa Biotech beat analyst estimates for earnings per share the fourth quarter of 2023.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 783

Day's Range $4.46 - $4.51

52-Week Range $0.39 - $8.33

Dividend & Yield N/A (N/A)

EDSA Stock Predictions, Articles, and Edesa Biotech Inc News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Jul 17, 2023

It's time to start off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday!

What Is Going on With Edesa Biotech (EDSA) Stock Today?

By Josh Enomoto, InvestorPlace Contributor Sep 30, 2022

Edesa Biotech released encouraging Phase 2 results for its respiratory-syndrome-targeting antibody, thus initially boosting EDSA stock.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Sep 21, 2021

Good morning, trader! Another busy day of trading is already underway as we look at the biggest pre-market stock movers for Tuesday!

EDSA Stock: The Covid-19 News Sending Edesa Biotech Soaring on Monday

By Chris MacDonald, InvestorPlace Contributor Sep 20, 2021

Today, the announcement of positive clinical trial results has sent investors in Edesa Biotech and EDSA stock on a nice ride.

Edesa Biotech (EDSA) Stock Rockets Higher on Dermatitis Study Approval

By William White, InvestorPlace Writer Jun 20, 2019

Edesa Biotech (EDSA) stock is flying higher on Thursday after getting approval from the U.S. Food and Drug Administration (FDA).

Edesa Biotech falls after 1-for-7 reverse stock split announcement (NASDAQ:EDSA)

From Seeking Alpha Oct 10, 2023

Edesa Biotech stock falls 10% after announcement of 1-for-7 reverse stock split.

Edesa Biotech appoints CFO (NASDAQ:EDSA)

From Seeking Alpha Jun 27, 2023

Biopharmaceutical company Edesa Biotech (EDSA) said on Tuesday that its board has appointed Stephen Lemieux CFO, effective July 15.

Edesa stock slumps 30% amid skin rash drug's mixed phase 2b trial results

From Seeking Alpha Jan 17, 2023

Edesa Biotech (EDSA) stock fell ~33% on Tuesday after the company reported data from a phase 2b trial of skin disorder therapy EB01The company is exploring EB01 as a monotherapy...

Edesa (NASDAQ:EDSA) Rises on Promising Phase 2 ARDS Results

From TipRanks Sep 30, 2022

Edesa Biotech (NASDAQ:EDSA) shares are on the rise today on the back of promising results from the Phase 2 part of its Phase 2/ Phase 3 study evaluating Edesa’s EB0...

Edesa Biotech (EDSA) Gets a Buy from H.C. Wainwright

From TipRanks Sep 8, 2022

In a report released today, Vernon Bernardino from H.C. Wainwright reiterated a Buy rating on Edesa Biotech (EDSA – Research Report), with a price target of $...

Edesa Biotech (EDSA) Gets a Buy from H.C. Wainwright

From TipRanks Aug 17, 2022

H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on Edesa Biotech (EDSA – Research Report) today and set a price target of $16.00. The compan...

ADVERTISEMENT